Evidence map›Paper›PMID 42050325›Full record

ArticleNature communications2026

Complement inhibition by a unique cluster of immunomodulatory outer surface proteins of Borrelia recurrentis.

Florian Röttgerding, Flavia Reyer, Eva Gerlach, Martin Amborn, Nadine Duschek, Tilman Gunter Schultze, Volker Fingerle, Christopher M Roome, Michaela Stumpf, Katja Becker and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Florian Röttgerding *Goethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.
Flavia Reyer *Goethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.
Eva GerlachGoethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.ORCID 0009-0003-9511-6101
Martin AmbornGoethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.
Nadine DuschekGoethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.
Tilman Gunter SchultzeGoethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany.
Volker FingerleNational Reference Center for Borrelia, Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.ORCID 0000-0002-3835-5646
Christopher M RoomeMax-Planck-Institute for Medical Research, Heidelberg, Germany.
Michaela StumpfBiochemistry and Molecular Biology, Interdisciplinary Research Centre, Justus Liebig University Giessen, Giessen, Germany.
Katja BeckerBiochemistry and Molecular Biology, Interdisciplinary Research Centre, Justus Liebig University Giessen, Giessen, Germany.
Stefan RahlfsBiochemistry and Molecular Biology, Interdisciplinary Research Centre, Justus Liebig University Giessen, Giessen, Germany.
Jude Marek PrzyborskiBiochemistry and Molecular Biology, Interdisciplinary Research Centre, Justus Liebig University Giessen, Giessen, Germany.ORCID 0000-0002-3494-7767
Peter KraiczyGoethe University Frankfurt, University Hospital, Institute for Medical Microbiology and Infection Control, Frankfurt, Germany. kraiczy@em.uni-frankfurt.de.ORCID 0009-0001-3167-1830
Karin Fritz-WolfMax-Planck-Institute for Medical Research, Heidelberg, Germany. karin.fritz-wolf@ernaehrung.uni-giessen.de.ORCID 0000-0002-4422-6795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Borrelia recurrentis, the agent of louse-borne relapsing fever, causes a poverty-associated, infectious disease of high mortality. Here, we identified and characterized five Complement targeting and Host Interacting proteins, ChiA to ChiE displaying immunomodulatory functions. Almost all Chi homologs inhibit complement activation by direct binding of key components, block membrane attack complex formation, and interact with plasminogen. Borrelia proteins protect susceptible spirochetes from complement-mediated killing and ChiB, ChiC, and ChiD facilitate serum resistance. X-ray structures of ChiA and ChiB, along with AlphaFold models of ChiC, ChiD, and ChiE, reveal a conserved, compact eight-helix fold with a central hydrophobic pocket and a unique S-domain-feature distinct from all known Borrelia proteins. Notably, ChiC and ChiE harbor conserved cysteines forming a reversible disulfide bridge, indicating redox-responsive function. Our findings identify a protein family of functionally related immune evasion factors, advancing our understanding of the underlying mechanisms of complement resistance in this neglected, human pathogenic microorganism.

Indexed as

Bacterial Outer Membrane ProteinsBorreliaComplement System ProteinsAmino Acid SequenceAnimalsComplement ActivationComplement Membrane Attack ComplexCrystallography, X-RayHumansModels, MolecularPlasminogenBacterial Outer Membrane ProteinsComplement Membrane Attack ComplexComplement System ProteinsPlasminogen

Identifiers

PMID42050325
PMCPMC13128870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.